Trials (Instituto Português de Oncologia de Coimbra Francisco Gentil): Revision history

15 December 2025

• curprev 13:3313:33, 15 December 2025‎ Francine talk contribs‎ 7,370 bytes +211‎ No edit summary undo

6 December 2025

• curprev 12:4112:41, 6 December 2025‎ Lucas talk contribs‎ m 7,159 bytes +1,701‎ Update categories. undo

4 December 2025

• curprev 15:2415:24, 4 December 2025‎ Larysse talk contribs‎ 5,458 bytes +50‎ No edit summary undo

2 December 2025

• curprev 13:5913:59, 2 December 2025‎ Lucas talk contribs‎ m 5,408 bytes +90‎ Update categories. undo

5 December 2023

• curprev 14:2014:20, 5 December 2023‎ Francine talk contribs‎ 5,318 bytes +5,318‎ Created page with "{{forpatients}} {{forresearchers}} {{forproviders}} Go back to Instituto Português de Oncologia de Coimbra Francisco Gentil page '''NCTID''': NCT04459715 '''Title''': A Study of Xevinapant (Debio 1143) in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Participants With Locally Advanced Squamous Cell Carcinoma of the Head and Neck, Suitable for Definitive Chemoradiotherapy (TrilynX) '''Study Summary'''..."